Showing results (201-210 of 395) with videos related to

Sort By:
Pageof 40
Journal of Neurosurgery|April 22, 2004
Prognostic value of allelic losses and telomerase activity in meningiomasPascal Leuraud, Edouard Dezamis, Lucinda Aguirre-Cruz, et al.
Cancer Investigation|January 7, 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent GlioblastomaMarianne Labussière, Caroline Cheneau, Claudia Prahst, et al.
Neuro-Oncology|February 7, 2019
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopyFrancesca Branzoli, Clément Pontoizeau, Lucien Tchara, et al.
Acta Neuropathologica Communications|April 3, 2016
Characteristics of gliomas in patients with somatic IDH mosaicismCharlotte Bonnet, Laure Thomas, Dimitri Psimaras, et al.
Journal of Neuro-Oncology|September 16, 2025
Prevalence, natural history and surgical outcome of spinal meningiomas in NF2-related schwannomatosisLouise Deboeuf, Antoine Keraudy, Thiebaud Picart, et al.
British Journal of Cancer|June 15, 2018
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodiesClément Vialatte de Pémille, Giulia Berzero, Mathilde Small, et al.
The Oncologist|July 13, 2016
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated GliomasMarianne Labussière, Amithys Rahimian, Marine Giry, et al.
Neuro-Oncology Advances|February 4, 2022
Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastomaBaptiste Sourty, Laure-Marie Dardaud, Céline Bris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomasMarc Sanson, Yannick Marie, Sophie Paris, et al.
Pageof 40